Our Distinguished Lecture Series returns to The Venue on Thursday 10 October with Sir Gregory Winter FRS.
Greg Winter studied Natural Sciences at the University of Cambridge and went on to do his PhD at the Laboratory of Molecular Biology. His main research focus is genetic and protein engineering.
A pioneer of humanised and human therapeutic antibodies, his techniques led to antibody therapies for cancer and diseases such as rheumatoid arthritis and multiple sclerosis.
Sir Gregory is a Fellow of Trinity College, Cambridge and has been Master of Trinity since 2012. He was elected a member of the European Molecular Biology Organisation in 1987, a Fellow of the Royal Society in 1990 and Fellow of the Academy of Medical Sciences in 2006.
In order to see his technologies applied, he established extremely successful companies including: Cambridge Antibody Technology (acquired by AstraZeneca), Domantis (acquired by GlaxoSmithKline) and Bicycle Therapeutics.
He received a knighthood for services to molecular biology in 2004 and has been awarded many prizes and medals, including the 2018 Nobel Prize for Chemistry.
The lecture, entitled ‘Harnessing the power of evolution for making new medicines’ will begin at 3pm and last approximately one hour. There will be a drinks reception with canapés following the lecture.
Posted on Wednesday 2 October 2019